Communication Immunization Pharmaceutical Companies Vaccines 
pharmaphorum
JANUARY 31, 2022
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.
pharmaphorum
AUGUST 13, 2020
To take one local example, in the UK Pfizer is working with the National Schools Partnership to make its Superbugs and Vaccines education program suitable for home learning. Pfizer has four different mRNA platform vaccines in play against one-another: a radical new approach for them. About THE PLANNING SHOP.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
APRIL 6, 2023
Vaccines have been an essential part of protecting public health for decades. However, despite the overwhelming evidence for their effectiveness and safety, there has been an increasing trend of vaccine hesitancy in recent years. What is vaccine hesitancy? Are there any long-term risks with vaccines?
Pharmaceutical Technology
FEBRUARY 1, 2023
RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.
pharmaphorum
JULY 30, 2021
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health literacy has never been more important. When a person’s or community’s health literacy is poor, misinformation can quickly spread.
The Infectious Pharmacist
APRIL 6, 2021
There must be some way to communicate information a little more positively, though. . Pfizer sent out a press release on March 31 with results from a small study of their mRNA vaccine in patients 12 through 15 years of age. The study enrolled about 2,200 patients with half getting the mRNA vaccine and half getting placebo.
Pharmaceutical Technology
MAY 1, 2023
After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.
Expert insights. Personalized for you.
97 
Let's personalize your content